Hepatitis C
Showing NaN - NaN of 57
Hepatitis C Trial in Worldwide (Alisporivir, Peginterferon alfa-2a, Ribavirin)
Hepatitis C, Hepatocellular Carcinoma Trial in New Zealand, Spain, United States (Sofosbuvir, Ribavirin)
Completed
- Hepatitis C
- Hepatocellular Carcinoma
-
Los Angeles, California
- +14 more
Jun 16, 2016
Hepatitis C, Human Immunodeficiency Virus Trial in Puerto Rico, United States (SOF, RBV)
Completed
- Hepatitis C
- Human Immunodeficiency Virus
-
Birmingham, Alabama
- +26 more
Nov 14, 2014
Hepatitis C Trial in Worldwide (biological, drug, other)
Completed
- Hepatitis C
- Pegylated Interferon Alfa 2a
- +3 more
-
Birmingham, Alabama
- +115 more
Jul 16, 2014
Hepatitis C Trial in Worldwide (VCH-222 or matching , peginterferon alfa-2a, ribavirin)
Completed
- Hepatitis C
- VCH-222 or matching placebo
- +2 more
-
Marietta, Georgia
- +9 more
Feb 6, 2014
Hepatitis C, HIV Trial in Worldwide (telaprevir or matching , peginterferon alfa-2a, ribavirin (fixed dose))
Completed
- Hepatitis C
- HIV Infections
- telaprevir or matching placebo
- +3 more
-
Beverly Hills, California
- +15 more
Aug 2, 2013
Hepatitis C Virus Infection in HIV-Infected Children
Completed
- HIV Infections
- Hepatitis C
-
Birmingham, Alabama
- +38 more
Oct 30, 2012
Hepatitis C Trial in United States (Infergen and ribavirin)
Terminated
- Hepatitis C
- Infergen and ribavirin
-
Atlanta, Georgia
- +3 more
Oct 11, 2012
Hepatitis C Trial in United States (Locteron (controlled-release interferon alpha 2b), pegylated IFNa2b)
Completed
- Hepatitis C
- Locteron (controlled-release interferon alpha 2b)
- pegylated IFNa2b
-
Detroit, Michigan
- +4 more
Feb 1, 2012
HIV Infection, Hepatitis C Trial in Canada, United States (nelfinavir 1,250 mg twice daily, Zidovudine 300 mg twice daily,
Completed
- HIV Infection
- Hepatitis C
- nelfinavir 1,250 mg twice daily
- +2 more
-
Bakersfield, California
- +4 more
May 9, 2011